[1]
Organization, W.H. The burden of chronic diseases in the african region, preventing chronic diseases a vital investment.World Diabetes Foundation Summit; World Health Organization: Africa, 2007.
[2]
Mohammed, H.A.; Hagras, H. A type 2 fuzzy logic based system for basal metabolic rate prediction of diabetes patients in Sudan. IJCTT, 2020, 8(3), 95-104.
[3]
Krogsgaard-Larsen, P.; Christensen, S.; Kofod, H. The role of medicinal plants in drug development.Natural Products and Drug Development; , 1994, pp. 34-45.
[7]
Njike, G.N.; Watcho, P.; Kamanyi, A. Hypoglycaemic activity of the leaves extracts of Bersama engleriana in rats. African J. Traditional, Complementary Alternative Med., 2005, 2(3), 215-221.
[8]
Heywood, V.H. Flowering plants of the world, 2ed; Oxford University Press: New York, 1993.
[9]
Mathewos Anza, F.W. Solomon Libsu, Fikre Mamo, Milkyas Endale phytochemical screening and antibacterial activity of leaves extract of Bersama abyssinica. J. Adv. Bot. and Zoo., 2015, 3(2), 1-5.
[10]
Schmelzer, G.; Gurib-Fakim, A. plant resources of tropical Africa 11 (1). Medicinal plants 1. Wageningen/Leiden, PROTA foundation; Backhuys Publishers, 2008.
[11]
Amit, L. Phytochemistry and pharmacological activities of Bersama engleriana Guerke-An overview. Sexually Trans. Diseases (STD), 2010, 11, 12.
[12]
Schmelzer, G.H.; Gurib-Fakim, A Medicinal plants, Prota: Africa, 2008.
[13]
Kifle, Z.D.; Enyew, E.F. Evaluation of in vivo antidiabetic, in vitro α-amylase inhibitory, and in vitro antioxidant activity of leaves crude extract and solvent fractions of Bersama abyssinica fresen (Melianthaceae). J Evid Based Integr Med, 2020, 25, 2515690-20935827.
[15]
Satyajit, D.; Sarker, Z.L.; Alexander I., Gray. Natural products isolation-second edition. Biotechnology™; Humana Press Inc.: United Kingdom, 2006.
[17]
OCDE, O. Acute oral Toxicity: Up and Down Procedure. OECD. Guideline for the testing of chemicals, 2008, 425, 1-2.
[30]
Belayneh, Y.M.; Birru, E.M. Antidiabetic activities of hydromethanolic leaf extract of Calpurnia aurea (Ait.) Benth. Subspecies aurea (Fabaceae) in mice. Evid. Based Complement Alternat. Med., 2018, 2018.
[31]
Tomai, F.; Crea, F.; Gaspardone, A.; Versaci, F.; De Paulis, R.; Penta de Peppo, A.; Chiariello, L.; Gioffrè, P.A. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation, 1994, 90(2), pp.700-705.
[34]
Tas, S., Tas, B.; Bassalat, N.; Jaradat, N. In vivo, hypoglycemic, hypolipidemic and oxidative stress inhibitory activities of Myrtus communis L. fruits hydroalcoholic extract in normoglycemic and streptozotocin-induced diabetic rats. Biomed. Res., 2018. 29(13).
[35]
Daniel, R.S.; Devi, K.S.; Augusti, K.T.; Nair, C.R. Mechanism of action of antiatherogenic and related effects of Ficus bengalensis Linn. flavonoids in experimental animals. Indian J. Exp. Biol., 2003, 41(4), 296-303.
[39]
Kaleem, M.; Kirmani, D.; Asif, M.; Ahmed, Q. ; Bano, B. Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian J. Exp. Biol., 2006, 44(9), 745-8.
[45]
Hammeso, W.W.; Emiru, Y.K.; Ayalew Getahun, K.; Kahaliw, W. Antidiabetic and antihyperlipidemic activities of the leaf latex extract of Aloe megalacantha baker (Aloaceae) in streptozotocin-induced diabetic model. Evid. Based Complement. Alternat. Med., 2019, 2019
[46]
Zekeya, N. Analysis of phytochemical composition of Bersama abyssinica by gas chromatography-mass spectrometry. J. Pharmacogn. Phytochem., 2014, 3(4), 246-252.
[47]
Firdous, S. Phytochemicals for treatment of diabetes. Excil Journal, 13: 451-453, metabolomic approach. Diabetes, 2014, 62(2), 639-648.